generic names for glp-1 drugs There's still no Ozempic, but a lower-priced daily injected is coming GLP-1 diabetes and weight-loss drug
Description
Insulin resistance promotes Parkinsons disease through aberrant expression of -synuclein, mitochondrial dysfunction, and deregulation of the polo-like kinase 2 signaling
Semaglutide (Ozempic and Wegovy) resulted in a 14.9% reduction in body weight in clinical trials, while tirzepatide (Mounjaro and Zepbound) led to a 20.9% body weight reduction
Pederson RA, Brown JC
Most of the names on the list were relatively unsurprising
Other companies are exploring quadruple agonists that add amylin receptor activation to the mix
Biochemical and Biophysical Research Communications
